- Tytuł:
- [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
- Autorzy:
- Źródło:
-
Zhonghua zhong liu za zhi [
Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 May 23; Vol. 40 (5), pp. 384-389. - Typ publikacji:
- Comparative Study; Journal Article
- MeSH Terms:
-
Antineoplastic Agents/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Carcinoma, Renal Cell/*secondary
Indoles/*therapeutic use
Kidney Neoplasms/*drug therapy
Niacinamide/*analogs & derivatives
Phenylurea Compounds/*therapeutic usePyrroles /*therapeutic use
Antineoplastic Agents/adverse effects ; Carcinoma, Renal Cell/mortality ; Diarrhea/chemically induced ; Disease Progression ; Disease-Free Survival ; Hand-Foot Syndrome/etiology ; Humans ; Indoles/adverse effects ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Multivariate Analysis ; Neutropenia/chemically induced ; Niacinamide/adverse effects ; Niacinamide/therapeutic use ; Phenylurea Compounds/adverse effects ; Prognosis ; Proportional Hazards Models ;Pyrroles /adverse effects ; Retrospective Studies ; Risk Factors ; Sorafenib ; Sunitinib ; Thrombocytopenia/chemically induced ; Treatment Outcome
Czasopismo naukowe